6
DNKS0303.TXT

DNKS
Dankos Laboratories Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 31-Mar-2003
Fiscal Year Ends            : Dec
Months Covered in Income St : 3

Summary of Balance Sheet
  Receivables               :     186,738,934.01
  Inventories               :     108,871,935.75
  Current Assets            :     478,417,893.32
  Fixed Assets              :     120,404,505.86
  Other Asstes              :      24,174,507.25
  Total Assets              :     716,844,675.20
  Current Liabilities       :     194,384,636.65
  Longterm Liabiities       :     206,884,388.00
  Total Liabilities         :     401,269,024.65
  Authorized                :       2,550,000.00
  Paid-up Capital           :      89,302,500.00
  Par Value                 :                100
  Paid-up Capital Shares    :         893,025.00
  Retained Earnings         :     212,571,071.18
  Total Equity              :     309,542,946.63
  Minority Interest         :       6,032,703.92

Summary of Income Statement
  Total Sales               :     273,293,232.08
  Cost of Good Sold         :     140,336,074.67
  Gross Profit              :     132,957,157.41
  Operating Profit          :      50,646,060.20
  Other Income              :      -7,375,201.65
  Eearning Before Tax       :      43,270,858.55
  Tax                       :      12,972,603.39
  Net Income                :      30,138,855.93
  Closing Price             :             500.00

Per Share Data (Rp)
  Eps                       :             135.00
  Book Value                :             346.62

Financial Ratios
  Debt Equity Ratio (X)     :               1.30
  Roa (%)                   :              16.82
  Roe (%)                   :              38.95
  Npm (%)                   :              44.11
  Opm (%)                   :              74.13

Cash Flow
  CF from Operating Activities                        :      18,507,414.48
  CF from Investing Activities                        :     -31,230,014.47
  CF from Financing Activities                        :       2,253,576.10
  Net Increase in Cash & Cash Equivalent              :      -9,128,237.52
  Cash & Cash Equivalent at The Beginning of The Year :     118,177,358.15
  Cash & Cash Equivalent at The End of The Year       :     109,049,120.62

 
 
 
